Nasdaq:US$18.16 (-0.83) | HKEX:HK$30.35 (+0.00) | AIM:£2.90 (-0.14)
Search Result
Previous Article   |   Next Article
公告及新闻稿, 肿瘤学 / 免疫学 | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing